Is HemoHIM Banned? Legal Status by Country [2026 Update]

No, HemoHIM is not banned in any country. It is legally sold through Atomy's official channels in multiple markets across Asia, North America, Europe, and beyond. The confusion likely stems from a 2023 Hong Kong consumer advisory — which was a warning, not a ban. Here's the complete picture.

Where HemoHIM Is Officially Sold

HemoHIM is distributed by Atomy, a South Korean company with operations in over 25 countries. You can check current pricing and ordering details for your region. Key markets include:

• Asia Pacific: South Korea (home market), Japan, Taiwan, Thailand, Vietnam, Indonesia, Malaysia, Singapore, Philippines, Cambodia, Mongolia

• North America: United States, Canada, Mexico

• Europe: Germany, France, United Kingdom, Italy, Netherlands, Poland, Romania, and other EU markets

• Central Asia: Kazakhstan, Kyrgyzstan, Uzbekistan

• Other regions: Australia, New Zealand, Colombia, Brazil, UAE, India

The Hong Kong Advisory: Facts vs Misconceptions

In 2023, the Hong Kong Centre for Health Protection issued a public advisory about HemoHIM. This has been widely misinterpreted as a "ban." Here's what actually happened:

• What happened: One person developed acute hepatitis after consuming HemoHIM. The health authority issued a precautionary consumer advisory.

• What it was NOT: It was not a ban, recall, or regulatory prohibition. It was an informational advisory based on a single case.

• Context: A single case report cannot establish causation. The patient's full medical history and other medications were not publicly disclosed.

For a detailed scientific analysis of this case in the context of clinical trial data, read our HemoHIM liver safety review.

HemoHIM's Regulatory Standing

Far from being banned, HemoHIM holds significant regulatory credentials. It is manufactured by Kolmar BNH, which has received FDA facility registration with NAI status and Australian TGA recognition. In South Korea, HemoHIM is classified as an Individual Health Functional Food by the Ministry of Food and Drug Safety (MFDS) — a specific regulatory category that requires demonstrated health benefits.

Why This Misinformation Spreads

The "HemoHIM banned" narrative typically circulates for a few reasons:

1. Sensationalized headlines — health advisories get amplified on social media without context

1. Competitor marketing — rival supplement brands may amplify negative news

1. MLM skepticism — Atomy's network marketing model attracts scrutiny (read our honest Atomy company review for a balanced assessment)

How to Verify HemoHIM's Status in Your Country

If you want to confirm HemoHIM's availability and legal status in your specific country:

1. Check Atomy's official website for your country (global.atomy.com) to see if HemoHIM is listed in the product catalog

1. Check your national food/drug authority's website for any advisories or product registrations

1. Consult a healthcare provider if you have specific safety concerns about any supplement

Bottom Line

HemoHIM is not banned anywhere. It is legally available in 25+ countries through Atomy's official channels, holds FDA facility registration, TGA recognition, and Korean MFDS classification. The Hong Kong advisory was a single-case consumer warning, not a ban or regulatory action. Always purchase through official channels and consult your healthcare provider with specific concerns. To understand the full safety profile of HemoHIM, review our evidence-based guides.